Latest University of Alabama at Birmingham Stories
UAB researchers developed a new vehicle to release proteins with therapeutic effects.
A new study published this week in the Journal of the American Medical Association suggests that the lung capacity of marijuana smokers is not diminished by regular toking, even among those who smoked once or twice a week.
AREVA announced that its subsidiary AREVA Med has started a Phase 1 clinical trial for its lead product ²¹²Pb-TCMC-Trastuzumab in patients with HER-2 positive intra-abdominal cancers. Bethesda, MD (PRWEB) August 04, 2011 AREVA announced that its subsidiary AREVA Med has started a Phase 1 clinical trial for its lead product ²¹²Pb-TCMC-Trastuzumab in patients with HER-2 positive intra-abdominal cancers. The new trial (AREVAMED01) is an open label Phase 1, dose...
BIRMINGHAM, Ala., June 8, 2011 /PRNewswire/ -- SANYO North America Corporation (SANYO) Biomedical Solutions Division announces that its Cell Processing Work Station (CPWS), an integrated, stand-alone solution for GMP compliant processing and preparation of regenerative stem cell and cell therapies for research use, has been installed at the University of Alabama at Birmingham (UAB) as the nation's first installation of the CPWS, as well as marking SANYO's first to be installed outside of Japan.
- a study of the individuals in a group of people within a specific context and their relationships.
- In rhetoric, the description of any one's personal appearance.